Articaine Hydrochloride, Adrenaline 40 Mg/0.01 Mg Solution For Injection, 1.7 Ml Each; Atropine Sulfate Solution For Injection 1 Mg/1 Ml, In A 1 Ml Ampoule; Epinephrine 1.82 Mg/Ml, Solution For Injection, Ampoule; Ammonia, Solution For External Use, 10%, 100 Ml Each; Validol Tablets 60 Mg Each; Barbiturates In Combination With Drugs Of Other Groups Capsules (Ethyl Ester 10 Mg, Menthol Solution In Menthyl Ester Of Isovaleric Acid – 46 Mg, Phenobarbital – 9.8 Mg); Barbiturates In Combination With Drugs Of Other Groups (Valocordin), Oral Drops, 50 Ml Each; Diphenhydramine, Solution For Injection, 10 Mg/Ml, 1 Ml Each; Papaverine, Solution For Injection, 20 Mg/Ml, 2 Ml Each; Dexamethasone, Solution For Injection 4 Mg/Ml; Captopril/Hydrochlorothiazide, Tablets, 50/12.5 Mg Each; Captopril, Tablets, 25 Mg Each; Lidocaine, Spray, 10%, 38 G Each; Sodium Chloride, Solution For Infusion, 9 Mg/Ml 200 Ml; Nitroglycerin, Sublingual Tablets, 0.5 Mg Each; Nifedipine Oral Drops 2%, 5 Ml Bottle

Комунальне некомерційне підприємство Обласна клінічна стоматологічна поліклініка Івано-oранківської обласної ради Ukraine has Released a tender for Articaine Hydrochloride, Adrenaline 40 Mg/0.01 Mg Solution For Injection, 1.7 Ml Each; Atropine Sulfate Solution For Injection 1 Mg/1 Ml, In A 1 Ml Ampoule; Epinephrine 1.82 Mg/Ml, Solution For Injection, Ampoule; Ammonia, Solution For External Use, 10%, 100 Ml Each; Validol Tablets 60 Mg Each; Barbiturates In Combination With Drugs Of Other Groups Capsules (Ethyl Ester 10 Mg, Menthol Solution In Menthyl Ester Of Isovaleric Acid – 46 Mg, Phenobarbital – 9.8 Mg); Barbiturates In Combination With Drugs Of Other Groups (Valocordin), Oral Drops, 50 Ml Each; Diphenhydramine, Solution For Injection, 10 Mg/Ml, 1 Ml Each; Papaverine, Solution For Injection, 20 Mg/Ml, 2 Ml Each; Dexamethasone, Solution For Injection 4 Mg/Ml; Captopril/Hydrochlorothiazide, Tablets, 50/12.5 Mg Each; Captopril, Tablets, 25 Mg Each; Lidocaine, Spray, 10%, 38 G Each; Sodium Chloride, Solution For Infusion, 9 Mg/Ml 200 Ml; Nitroglycerin, Sublingual Tablets, 0.5 Mg Each; Nifedipine Oral Drops 2%, 5 Ml Bottle in Pharmaceuticals. The tender was released on Jan 14, 2025.

Country - Ukraine

Summary - Articaine Hydrochloride, Adrenaline 40 Mg/0.01 Mg Solution For Injection, 1.7 Ml Each; Atropine Sulfate Solution For Injection 1 Mg/1 Ml, In A 1 Ml Ampoule; Epinephrine 1.82 Mg/Ml, Solution For Injection, Ampoule; Ammonia, Solution For External Use, 10%, 100 Ml Each; Validol Tablets 60 Mg Each; Barbiturates In Combination With Drugs Of Other Groups Capsules (Ethyl Ester 10 Mg, Menthol Solution In Menthyl Ester Of Isovaleric Acid – 46 Mg, Phenobarbital – 9.8 Mg); Barbiturates In Combination With Drugs Of Other Groups (Valocordin), Oral Drops, 50 Ml Each; Diphenhydramine, Solution For Injection, 10 Mg/Ml, 1 Ml Each; Papaverine, Solution For Injection, 20 Mg/Ml, 2 Ml Each; Dexamethasone, Solution For Injection 4 Mg/Ml; Captopril/Hydrochlorothiazide, Tablets, 50/12.5 Mg Each; Captopril, Tablets, 25 Mg Each; Lidocaine, Spray, 10%, 38 G Each; Sodium Chloride, Solution For Infusion, 9 Mg/Ml 200 Ml; Nitroglycerin, Sublingual Tablets, 0.5 Mg Each; Nifedipine Oral Drops 2%, 5 Ml Bottle

Deadline - Jan 14, 2026

GT reference number - 101443715

Product classification - Medicinal products for the nervous system and sensory organs